On June 26, 2026, TECOGEN INC. granted CEO Rangesh Abinand 174,081 shares at $0 per share. The award left Abinand with 241,274 shares, giving investors a clear view of the chief executive’s reported post-transaction holding and the grant’s zero-dollar per-share terms.
Key Highlights
- Rangesh Abinand’s post-transaction ownership was reported at 241,274 TECOGEN INC. Shares.
- The award was dated June 26, 2026.
- Transaction code A classified the event as an award or grant.
TECOGEN INC. (AMEX: TGEN) awarded Chief Executive Officer Rangesh Abinand 174,081 shares at $0 per share. The transaction left Abinand with 241,274 shares, establishing his reported post-award ownership position.
CEO Award Recorded June 26 TECOGEN
recorded the award on June 26, 2026, with Rangesh Abinand identified as its chief executive officer. The shares carried a stated price of $0 per share. The 174,081-share grant and the 241,274-share ownership figure describe separate parts of the transaction record, with the latter representing Abinand’s holdings after the award. TECOGEN’s reported figures therefore show both the size of the Equity award and the resulting executive share position.
FAQs
Q: How many TECOGEN shares did Rangesh Abinand receive?
A: Rangesh Abinand received 174,081 TECOGEN INC. Shares. The shares were awarded at $0 per share in a transaction dated June 26, 2026.
Q: What was the impact on the TECOGEN CEO’s stock ownership?
A: Rangesh Abinand’s reported ownership following the award was 241,274 TECOGEN INC. Shares. The figure represents his holdings after the transaction.
Q: What does transaction code A mean for the TECOGEN share award?
A: Transaction code A describes the 174,081-share grant made to TECOGEN INC. CEO Rangesh Abinand. The award was recorded on June 26, 2026, at a stated price of $0 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.